Mouth Dissolving Tablets Market

Global Mouth Dissolving Tablets Market Size, Share & Trends Analysis Report, By Type (Anti-Psychotics Drug, Anti-Epileptics Drug, Other), By Application (CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other), Forecast (2021-2027)

Published: Jan 2022 | Report Code: OMR2025425 | Category : Pharmaceuticals | Delivery Format: /

The global mouth dissolving tablets market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor attributed to the market growth includes the better patient compliance of these tablets over the conventional tablets and capsules. The patient compliance is majorly due to the comparatively better taste of these orally disintegrating tablets than the traditional ones. Therefore, over the past decade, mouth dissolving tablets have gained considerable attention among the global population as a preferred alternative. 

It is generally seen that young children, infants, and the elderly populace who have swallowing problems find it difficult to swallow the traditional drugs. Therefore, to counter such complications, new product launches and development of various mouth dissolving tablets took place in the past decade that has also shown improved performance and suitability. As a result, these useful features of mouth dissolving tablets have backed the market growth all over the globe. For instance, as per a report released in Pediatric Praziquantel Consortium, 2019, named “Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children” found L-PZQ and Rac-PZQ more preferable, which in turn, improved the dosage compliance. In fact, in North African countries, Praziquantel (PZQ) was found to be the only recommended drug for schistosome infection and disease in April 2019. Furthermore, some key players operating in the market include Eli Lilly and Company, Mylan N.V., Otsuka Holdings Co., Ltd., among others.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape:  Eli Lilly and Company, Mylan N.V., Otsuka Holdings Co., Ltd., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Mouth Dissolving Tablets Market by Segments

By Type 

Anti-Psychotics Drug

Anti-Epileptics Drug

Other

By Application 

CNS Diseases

Gastrointestinal Diseases

CVS Diseases

Other 

Global Mouth Dissolving Tablets Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World